Related Experiment Video

Updated: May 8, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Role of E3 ubiquitin ligases in lung cancer

Barbara C Snoek1, Leonie Ham de Wilt, Gerrit Jansen

  • 1Barbara C Snoek, Leonie HAM de Wilt, Godefridus J Peters, Department of Medical Oncology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands.

World Journal of Clinical Oncology
|August 13, 2013
PubMed

Insights

E3 ubiquitin ligases are crucial for cell regulation but are often overexpressed in lung cancer. Targeting these enzymes offers a promising avenue for developing novel anti-cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • E3 ubiquitin ligases mediate protein ubiquitination, a key process for regulating cell cycle, proliferation, and apoptosis.
  • Deregulation of E3 ubiquitin ligases is implicated in human cancers, particularly lung cancer, contributing to tumorigenesis.
  • Targeting E3 ubiquitin ligases presents a therapeutic challenge due to a limited number of specific inhibitors in clinical trials.

Purpose of the Study:

  • To review E3 ubiquitin ligases deregulated in lung cancer.
  • To discuss their roles in biological processes and cancer development.
  • To evaluate their potential as anti-cancer therapeutic targets.

Main Methods:

  • Literature review focusing on E3 ubiquitin ligases in lung cancer.
  • Analysis of biological processes regulated by these enzymes.
  • Evaluation of their suitability as drug targets.

Main Results:

  • Several E3 ubiquitin ligases are identified as deregulated in lung cancer.
  • These enzymes play critical roles in cell cycle control and apoptosis pathways relevant to cancer.
  • Their involvement in carcinogenesis highlights their potential as therapeutic targets.

Conclusions:

  • Understanding E3 ubiquitin ligase mechanisms in cancer is vital for developing targeted therapies.
  • Specific E3 ubiquitin ligase inhibitors could offer novel treatment strategies for lung cancer patients.
  • Further research into these enzymes may unlock new avenues for cancer treatment.
Keywords:
ApoptosisBortezomibDNA repairE3 ubiquitin ligasesGene regulationLung cancerProteasome inhibitorsUbiquitin-proteasome system

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...